Autoantibodies in patients with bronchial carcinoma.
AUTOR(ES)
Hodson, M E
RESUMO
No overall increase in the incidence of antinuclear, smooth muscle or reticulin antibodies was observed in a group of 105 patients with bronchial carcinoma of various classified histological types. Smooth muscle antibody was, however, demonstrated in 27% of patients with undifferentiated carcinoma compared to 5% of controls (P less than 0-05). A highly significant increase in antinuclear antibodies in patients with adenocarcinoma was found (31% compared with 5% of controls--P less than 0-01). There as no apparent correlation between the presence of these antibodies and age, sex or other clinical features studied. A detailed study of the reproducibility of the antibody results, studied by indirect immunofluorescence in patients with bronchial carcinoma, is reported.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=470296Documentos Relacionados
- Mediastinoscopy in the management of patients with bronchial carcinoma.
- Quality of survival in patients with surgically treated bronchial carcinoma.
- Lung scanning in bronchial carcinoma.
- Detection of occult cardiac invasion by two dimensional echocardiography in patients with bronchial carcinoma.
- Adjuvant immunotherapy with BCG in squamous cell bronchial carcinoma.
